EVIDENCES-X™ global Phase II(b) clinical trial of Saroglitazar Mg in MASH has been successfully completed. The trial achieved its primary endpoint of resolution of steatohepatitis…
EVIDENCES-X™ global Phase II(b) clinical trial of Saroglitazar Mg in MASH has been successfully completed. The trial achieved its primary endpoint of resolution of steatohepatitis…
Dongguan China facility receives registration to support production of medical devices for the USA market. Woking, UK, 07 December 2023. TT Electronics received approval from…